Clinical Trials Browser

Phase 2 × Unknown × HR-positive, HER2-negative Advanced Breast Cancer × Clear all

NCT04796623 2021-03-15

A Study of TQB3616 Capsules Combined With Fulvestrant Injection in Subjects With Advanced Breast Cancer

Phase 2 Unknown

HR-positive, HER2-negative Advanced Breast Cancer